Business

At Teramyst Corp, our business model combines near-term revenue from premium OEM products with long-term value creation through proprietary R&D and ODM innovation. This dual-track approach lets us operate profitably today while building defensible intellectual property for tomorrow.

Revenue Model

• OEM-led Launch: Flagship products—Teramyst Immune+ and Teramyst Focus+ Boost—are produced via FDA-registered, GMP-certified partners (e.g., VitaQuest) and sold under the Teramyst brand.
• ODM/IP Pipeline: Proprietary formulations and novel ingredient combinations developed with researchers in the U.S., Korea, and Japan to secure differentiation and margin protection.
• Recurring Programs: Subscriptions, bundles, and loyalty benefits to increase retention and lifetime value.

Sales & Distribution

• E-commerce First: Amazon (U.S./EU) and teramyst.com with performance marketing, credible product pages, and verified reviews.
• Select Retail & Clinical: Placement in premium health stores, clinics, and pharmacies aligned with our science-first positioning.
• International Expansion: Compliance-led entry into APAC and selected Middle Eastern markets with experienced regional distributors.

Brand & Positioning

• Science-Driven: Transparent ingredient sourcing, concise clinical substantiation, and quality documentation.
• Premium Yet Practical: One-capsule-a-day convenience with research-backed dosages and clean labels.
• Trusted Communication: Clear claims, responsible messaging, and education-first content.

Operations & Compliance

• Quality System: SOPs for documentation, lot traceability, stability checks, and label/regulatory reviews.
• Supply Assurance: Vetted suppliers for capsules, bottles, and labels; demand planning to de-risk scale-up.
• Data-Driven Decisions: Dashboarding for CAC payback, contribution margin, retention, and review velocity.

How We Scale

We operate through three centers—Planning (roadmaps, partnerships, brand), Business (commerce, operations, compliance), and Research (R&D collaborations, clinical evidence, documentation). This structure keeps us lean, focused, and execution-oriented.

Outlook

With a solid foundation in premium manufacturing, evidence-based product design, and global distribution, Teramyst is positioned to expand into broader health supplementation and, over time, to explore pharmaceutical-adjacent developments. Our goal is to build durable IP and a multi-channel wellness platform that delivers measurable value to customers worldwide.

We are strengthening our R&D capabilities with the support of accomplished researchers whose proven track records ensure both credibility and innovation—enabling Teramyst to bridge the gap between wellness and medicine.